As the world continues its battle against antibiotic-resistant infections, one powerful player is stepping into the spotlight: daptomycin. Once reserved for serious hospital-acquired infections, this potent antibiotic is now taking center stage in the global antimicrobial resistance (AMR) fight. And behind the scenes, the Daptomycin Market is quietly building momentum—set to explode in...